Maralixibat for Intrahepatic Cholestasis of Pregnancy

Starting soon · Phase 2

Conditions studied: Intrahepatic Cholestasis of Pregnancy

In brief

An open label phase 2a/b trial of maralixibat in patients with Intrahepatic Cholestasis of Pregnancy (ICP) and elevated serum bile acid concentrations (sBA) to evaluate safety and tolerability

Key facts

Study ID
NCT07389031
Run by
Imperial College London
People needed
28
Starts
2026-04-01
Expected to finish
2028-03-31
Last updated by the study team
2026-02-05

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.